Clinical Decision Support
Clinical Decision Support: A clinical decision support system is a health information technology system that is designed to provide physicians and other health professionals with clinical decision support, that is, assistance with clinical decision-making tasks.
-
JUL 30, 2019 06:00 AM PDTC.E. CREDITS
JUL 30, 2019 06:00 AM PDTDATE: July 30, 2019TIME: 6:00am PT, 9:00am ET The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance...Speaker: Erick Nfon, PhDSponsored By: SmithersJUN 12, 2019 10:00 AM PDTC.E. CREDITS
JUN 12, 2019 10:00 AM PDTDATE: June 12, 2019TIME: 10:00am PT/1:00pm ET With the ever-changing healthcare ecosystem, you are being asked to continually perform better than ever before. Your patients con...Speaker: Todd Wharton, RN , Katherine Metz, BSN, MBA, RNSponsored By: Abbott DiagnosticsAPR 10, 2019 01:30 PM PDTC.E. CREDITS
APR 10, 2019 01:30 PM PDTMyeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...Speaker: Véronique Laloux, PhD , Beate Litzenburger, PhDPresented At:Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 10:30 AM PDTC.E. CREDITS
APR 10, 2019 10:30 AM PDTQIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions,...Speaker: Sheryl Elkin, PhD , Dan Richards, PhDPresented At:Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 10:30 AM PDTC.E. CREDITS
APR 10, 2019 10:30 AM PDTThe BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...Speaker: Anika Joecker, PhD , Jennifer Poitras, PhDPresented At:Molecular Diagnostics 2019Sponsored By: QIAGENMAR 13, 2019 11:20 AM PDTC.E. CREDITS
MAR 13, 2019 11:20 AM PDTJoin us in this unique opportunity to discuss neuroethics and innovative neurotechnologies....Speaker: Khara Ramos, PhD , Nader Pouratian, MD, PhD , Ashley Feinsinger, PhD , Francis Shen, JD, PhD , Saskia Hendriks, MD, PhDPresented At:Neuroscience 2019MAR 13, 2019 09:10 AM PDTC.E. CREDITS
MAR 13, 2019 09:10 AM PDTJoin us in this unique opportunity to directly address awardees of the research on humans division of BRAIN Initiative....Speaker: Elizabeth Buffalo, PhD , Ueli Rutishauser, PhD , Jennifer Collinger, PhDPresented At:Neuroscience 2019MAR 13, 2019 08:00 AM PDTC.E. CREDITS
MAR 13, 2019 08:00 AM PDTThe rapid formation of new memories and the recall of old memories to inform decisions is essential for human cognition, but the underlying neural mechanisms remain poorly understood. We util...Speaker: Ueli Rutishauser, PhDPresented At:Neuroscience 2019MAR 13, 2019 07:00 AM PDTC.E. CREDITS
MAR 13, 2019 07:00 AM PDTNIH representatives from the BRAIN Initiative will be presenting an overview of the NIH BRAIN Initiative and describing funding opportunity announcements (FOAs) supporting impacts in human ne...Speaker: James Gnadt, PhD , Karen David, PhDPresented At:Neuroscience 2019DEC 13, 2018 09:00 AM PSTC.E. CREDITS
DEC 13, 2018 09:00 AM PSTDATE: December 13 15,2018TIME: 09:00am PST, 12:00pm EST Breast cancers are classified into three main subtypes according to their receptor status: estrogen receptor-positive...Speaker: Hillary Stires, PhDSponsored By: Thermo Fisher Scientific/GibcoNOV 15, 2018 12:00 PM PSTC.E. CREDITS
NOV 15, 2018 12:00 PM PSTQIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present a lung cancer case study to show how QIAG...Speaker: Raed Samara, PhD , Dan Richards, PhDPresented At:Clinical Diagnostics & Research 2018Sponsored By: QIAGENNOV 14, 2018 08:00 AM PST
NOV 14, 2018 08:00 AM PSTDATE: November 14, 2018TIME: 08:00am PST, 11:00am EST International Genetics & Translational Research in Transplantation Network (iGeneTRAIN) has recently generated genome...Speaker: Brendan Keating, DPhilSponsored By: Thermo Fisher ScientificOCT 16, 2018 07:00 AM PDTC.E. CREDITS
OCT 16, 2018 07:00 AM PDTDATE: October 16, 2018TIME: 7:00am PDT, 10:00am EDT In today’s healthcare environment, leaders are increasingly asked to demonstrate value in terms...Speaker: Patrick Gontard , Paul Clarke , Jose Santiago, PhDSponsored By: Abbott DiagnosticsJUN 21, 2018 09:00 AM PDTC.E. CREDITS
JUN 21, 2018 09:00 AM PDTFinding effective treatments for cancer is fundamentally a high-dimensional probabilistic planning, search, and optimization problem, characterized by thousands of molecular subty...Speaker: Marty Tenenbaum, PhDPresented At:Precision Medicine 2018JUN 20, 2018 01:30 PM PDTC.E. CREDITS
JUN 20, 2018 01:30 PM PDTRegulation of precision medicine is rapidly evolving. The pre-existing regulatory framework did not contemplate many of the products and technologies which are becoming available with p...Speaker: Neil BelsonPresented At:Precision Medicine 2018JUN 20, 2018 09:00 AM PDTC.E. CREDITS
JUN 20, 2018 09:00 AM PDTWith prospective clinical sequencing of tumors emerging as a mainstay in cancer care, there is an urgent need for clinical support tools that aid clinicians in their decision making. To this...Speaker: Nikolaus Schultz, PhDPresented At:Precision Medicine 2018NOV 08, 2017 01:30 PM PSTC.E. CREDITS
NOV 08, 2017 01:30 PM PSTThe advent of next generation sequencing has transformed the way we identify mutations with clinical implications. As the compendium of variants expands, gathering the most current and accura...Speaker: Jennifer Poitras, PhDPresented At:Clinical Diagnostics & Research 2017OCT 25, 2017 10:00 AM PDTC.E. CREDITS
OCT 25, 2017 10:00 AM PDTDATE: October 25, 2017TIME: 10:00am PDT, 1:00pm EDTTesting for antinuclear antibodies (ANAs) has been a routine part of the evaluation of patients with a suspected connective tissue dis...Speaker: Gyorgy Abel, MD, PhD, DABCC , Melissa Snyder, PhD, DABCCSponsored By: Bio-Rad LaboratoriesSEP 14, 2017 06:00 AM PDTC.E. CREDITS
SEP 14, 2017 06:00 AM PDTINTRODUCTION: The recent coincidental emergence of the human microbiota and the Hologneomic Theory of Co-evolution unmasked the “Dual Citizenship” of symbiotic microbes and...Speaker: John Thomas, PhDPresented At:Microbiology & Immunology 2017APR 13, 2017 10:30 AM PDTC.E. CREDITS
APR 13, 2017 10:30 AM PDTNext-generation sequencing is expected to take molecular diagnostics to the next level with the capability to perform deep analysis of genetic information that leads to targeted therapies per...Speaker: Condie Carmack, PhD , Ahmed Mahmoud, PhDPresented At:Molecular Diagnostics 2017Sponsored By: Vela DiagnosticsAPR 12, 2017 09:00 AM PDTC.E. CREDITS
APR 12, 2017 09:00 AM PDTScreening for cervical cancer represents one of the greatest successes achieved in disease prevention. Cytology has been central to cervical cancer screening programs for over 50 years and ha...Speaker: Catherine Behrens, MD, PhD, FACOGPresented At:Molecular Diagnostics 2017Sponsored By: Roche DiagnosticsFEB 22, 2017 06:00 AM PSTC.E. CREDITS
FEB 22, 2017 06:00 AM PSTThe starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...Speaker: Marc Williams, MDPresented At:Precision Medicine 2017NOV 03, 2016 12:00 PM PDTC.E. CREDITS
NOV 03, 2016 12:00 PM PDTBreast cancer is a complex heterogeneous disease, with each subtype characterized by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented mas...Speaker: Julie Deschenes, MBA, PhD , Dilhan Weeraratne, PhDPresented At:Clinical Diagnostics & ResearchNOV 02, 2016 01:30 PM PDTC.E. CREDITS
NOV 02, 2016 01:30 PM PDTToday there are about 7B mobile phone worldwide and about 50,000 mobile health applications actively changing the landscape of how healthcare will be delivered in the next years. While numero...Speaker: John McDevitt, PhDPresented At:Clinical Diagnostics & Research
JUL 30, 2019
06:00 AM PDT
C.E. CREDITS
JUL 30, 2019
06:00 AM PDT
DATE: July 30, 2019TIME: 6:00am PT, 9:00am ET The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance...
Speaker:
Erick Nfon, PhD
Sponsored By: Smithers
JUN 12, 2019
10:00 AM PDT
C.E. CREDITS
JUN 12, 2019
10:00 AM PDT
DATE: June 12, 2019TIME: 10:00am PT/1:00pm ET With the ever-changing healthcare ecosystem, you are being asked to continually perform better than ever before. Your patients con...
Speaker:
Todd Wharton, RN
,
Katherine Metz, BSN, MBA, RN
Sponsored By: Abbott Diagnostics
APR 10, 2019
01:30 PM PDT
C.E. CREDITS
APR 10, 2019
01:30 PM PDT
Myeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...
Speaker:
Véronique Laloux, PhD
,
Beate Litzenburger, PhD
Presented At:Molecular Diagnostics 2019
Sponsored By: QIAGEN
APR 10, 2019
10:30 AM PDT
C.E. CREDITS
APR 10, 2019
10:30 AM PDT
QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions,...
Speaker:
Sheryl Elkin, PhD
,
Dan Richards, PhD
Presented At:Molecular Diagnostics 2019
Sponsored By: QIAGEN
APR 10, 2019
10:30 AM PDT
C.E. CREDITS
APR 10, 2019
10:30 AM PDT
The BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...
Speaker:
Anika Joecker, PhD
,
Jennifer Poitras, PhD
Presented At:Molecular Diagnostics 2019
Sponsored By: QIAGEN
MAR 13, 2019
11:20 AM PDT
C.E. CREDITS
MAR 13, 2019
11:20 AM PDT
Join us in this unique opportunity to discuss neuroethics and innovative neurotechnologies....
Speaker:
Khara Ramos, PhD
,
Nader Pouratian, MD, PhD
,
Ashley Feinsinger, PhD
,
Francis Shen, JD, PhD
,
Saskia Hendriks, MD, PhD
Presented At:Neuroscience 2019
MAR 13, 2019
09:10 AM PDT
C.E. CREDITS
MAR 13, 2019
09:10 AM PDT
Join us in this unique opportunity to directly address awardees of the research on humans division of BRAIN Initiative....
Speaker:
Elizabeth Buffalo, PhD
,
Ueli Rutishauser, PhD
,
Jennifer Collinger, PhD
Presented At:Neuroscience 2019
MAR 13, 2019
08:00 AM PDT
C.E. CREDITS
MAR 13, 2019
08:00 AM PDT
The rapid formation of new memories and the recall of old memories to inform decisions is essential for human cognition, but the underlying neural mechanisms remain poorly understood. We util...
Speaker:
Ueli Rutishauser, PhD
Presented At:Neuroscience 2019
MAR 13, 2019
07:00 AM PDT
C.E. CREDITS
MAR 13, 2019
07:00 AM PDT
NIH representatives from the BRAIN Initiative will be presenting an overview of the NIH BRAIN Initiative and describing funding opportunity announcements (FOAs) supporting impacts in human ne...
Speaker:
James Gnadt, PhD
,
Karen David, PhD
Presented At:Neuroscience 2019
DEC 13, 2018
09:00 AM PST
C.E. CREDITS
DEC 13, 2018
09:00 AM PST
DATE: December 13 15,2018TIME: 09:00am PST, 12:00pm EST Breast cancers are classified into three main subtypes according to their receptor status: estrogen receptor-positive...
Speaker:
Hillary Stires, PhD
Sponsored By: Thermo Fisher Scientific/Gibco
NOV 15, 2018
12:00 PM PST
C.E. CREDITS
NOV 15, 2018
12:00 PM PST
QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present a lung cancer case study to show how QIAG...
Speaker:
Raed Samara, PhD
,
Dan Richards, PhD
Presented At:Clinical Diagnostics & Research 2018
Sponsored By: QIAGEN
NOV 14, 2018
08:00 AM PST
NOV 14, 2018
08:00 AM PST
DATE: November 14, 2018TIME: 08:00am PST, 11:00am EST International Genetics & Translational Research in Transplantation Network (iGeneTRAIN) has recently generated genome...
Speaker:
Brendan Keating, DPhil
Sponsored By: Thermo Fisher Scientific
OCT 16, 2018
07:00 AM PDT
C.E. CREDITS
OCT 16, 2018
07:00 AM PDT
DATE: October 16, 2018TIME: 7:00am PDT, 10:00am EDT In today’s healthcare environment, leaders are increasingly asked to demonstrate value in terms...
Speaker:
Patrick Gontard
,
Paul Clarke
,
Jose Santiago, PhD
Sponsored By: Abbott Diagnostics
JUN 21, 2018
09:00 AM PDT
C.E. CREDITS
JUN 21, 2018
09:00 AM PDT
Finding effective treatments for cancer is fundamentally a high-dimensional probabilistic planning, search, and optimization problem, characterized by thousands of molecular subty...
Speaker:
Marty Tenenbaum, PhD
Presented At:Precision Medicine 2018
JUN 20, 2018
01:30 PM PDT
C.E. CREDITS
JUN 20, 2018
01:30 PM PDT
Regulation of precision medicine is rapidly evolving. The pre-existing regulatory framework did not contemplate many of the products and technologies which are becoming available with p...
Speaker:
Neil Belson
Presented At:Precision Medicine 2018
JUN 20, 2018
09:00 AM PDT
C.E. CREDITS
JUN 20, 2018
09:00 AM PDT
With prospective clinical sequencing of tumors emerging as a mainstay in cancer care, there is an urgent need for clinical support tools that aid clinicians in their decision making. To this...
Speaker:
Nikolaus Schultz, PhD
Presented At:Precision Medicine 2018
NOV 08, 2017
01:30 PM PST
C.E. CREDITS
NOV 08, 2017
01:30 PM PST
The advent of next generation sequencing has transformed the way we identify mutations with clinical implications. As the compendium of variants expands, gathering the most current and accura...
Speaker:
Jennifer Poitras, PhD
Presented At:Clinical Diagnostics & Research 2017
OCT 25, 2017
10:00 AM PDT
C.E. CREDITS
OCT 25, 2017
10:00 AM PDT
DATE: October 25, 2017TIME: 10:00am PDT, 1:00pm EDTTesting for antinuclear antibodies (ANAs) has been a routine part of the evaluation of patients with a suspected connective tissue dis...
Speaker:
Gyorgy Abel, MD, PhD, DABCC
,
Melissa Snyder, PhD, DABCC
Sponsored By: Bio-Rad Laboratories
SEP 14, 2017
06:00 AM PDT
C.E. CREDITS
SEP 14, 2017
06:00 AM PDT
INTRODUCTION: The recent coincidental emergence of the human microbiota and the Hologneomic Theory of Co-evolution unmasked the “Dual Citizenship” of symbiotic microbes and...
Speaker:
John Thomas, PhD
Presented At:Microbiology & Immunology 2017
APR 13, 2017
10:30 AM PDT
C.E. CREDITS
APR 13, 2017
10:30 AM PDT
Next-generation sequencing is expected to take molecular diagnostics to the next level with the capability to perform deep analysis of genetic information that leads to targeted therapies per...
Speaker:
Condie Carmack, PhD
,
Ahmed Mahmoud, PhD
Presented At:Molecular Diagnostics 2017
Sponsored By: Vela Diagnostics
APR 12, 2017
09:00 AM PDT
C.E. CREDITS
APR 12, 2017
09:00 AM PDT
Screening for cervical cancer represents one of the greatest successes achieved in disease prevention. Cytology has been central to cervical cancer screening programs for over 50 years and ha...
Speaker:
Catherine Behrens, MD, PhD, FACOG
Presented At:Molecular Diagnostics 2017
Sponsored By: Roche Diagnostics
FEB 22, 2017
06:00 AM PST
C.E. CREDITS
FEB 22, 2017
06:00 AM PST
The starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...
Speaker:
Marc Williams, MD
Presented At:Precision Medicine 2017
NOV 03, 2016
12:00 PM PDT
C.E. CREDITS
NOV 03, 2016
12:00 PM PDT
Breast cancer is a complex heterogeneous disease, with each subtype characterized by distinct clinical features and molecular alterations. The heterogeneity of breast cancer has presented mas...
Speaker:
Julie Deschenes, MBA, PhD
,
Dilhan Weeraratne, PhD
Presented At:Clinical Diagnostics & Research
NOV 02, 2016
01:30 PM PDT
C.E. CREDITS
NOV 02, 2016
01:30 PM PDT
Today there are about 7B mobile phone worldwide and about 50,000 mobile health applications actively changing the landscape of how healthcare will be delivered in the next years. While numero...
Speaker:
John McDevitt, PhD
Presented At:Clinical Diagnostics & Research